Adaptive Biotechnologies GAAP EPS of -$0.09 beats by $0.09, revenue of $71.7M beats by $10.8M
Source: SeekingAlpha
2026-02-05 16:15:31 ET
More on Adaptive Biotechnologies
- Adaptive Biotechnologies Corporation (ADPT) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Adaptive Biotechnologies Corporation (ADPT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Adaptive Biotechnologies: 2026 Is The Durability Test, Not The Hype Cycle
- Adaptive Biotechnologies Q4 2025 Earnings Preview
- Adaptive Biotechnologies reports prelim Q4, FY revenue above estimate; shares up
Read the full article on Seeking Alpha
For further details see:
Adaptive Biotechnologies GAAP EPS of -$0.09 beats by $0.09, revenue of $71.7M beats by $10.8M
Adaptive Biotechnologies Corporation
NASDAQ: ADPT
ADPT Trading
2.77% G/L:
$14.85 Last:
815,289 Volume:
$14.95 Open:
ADPT Latest News
February 05, 2026 04:05:00 pm
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results
January 22, 2026 04:05:00 pm
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
ADPT Stock Data
$2,393,790,148
142,894,616
2.45%
99
N/A
Biotechnology & Life Sciences
Healthcare
US
Seattle
